Search for a clinical trial
Other search option(s)
4 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
A randomized, double-blind, double-dummy active-comparator, multicenter study to evaluate the efficacy and safety of rituximab versus MMF in patients with pemphigus vulgaris -FR
Institution: Information not provided - FR
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
PEMPA : Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid (Phase III)
CHU de Bordeaux - Hôpital Saint André
Service de Dermatologie adulte et pédiatrique
GERMANY
Hessen
MARBURG
TPV11: A multi-centre, open-label, phase 1 study, Part A single ascending dose and Part B multiple dose, to evaluate the safety, tolerability and pharmacokinetics, and to explore early signs of effectiveness of induction of antigen-specific immune tolerance with TPM203 in pemphigus vulgaris patients (PEGASUS: SP 8)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Dermatologie und Allergologie
Multinational clinical trial(s)
UNITED STATES
California
SOUTH SAN FRANCISCO